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Differences in the natm'e of the gangliosides present in two types of Ehrlich ascites tun:our (EAT) cells, the 
adherent and non-adherent EAT cells, were studied. Gangliosides were isolated by DEAE Sephadex column 
chromatography and analysed by high-performance thin-layer chromatography (HPTLC). The non-adherent EAT 
(ha-EAT) cells which grow in the peritoneal cavity of mice were selected for growth on basement membrane and 
tissue culture plastic to give the adherent EAT (a-EAT) cells, na-EAT cells contained 1 +57 nmol lipid-bound sialic 
acid per mg protein and at least 12 different gangliosides, including major gangliosides such as GM3, GM2, GM1, 
GD3, GDla and GTlb. On the other hand, the ganglioside pattern of a-EAT cells differed significantly from that of 
ha-EAT cells, both quantitatively and qualitatively. The content of lipid-bound sialic acid in a-EAT cells was only 
0.24 nmol per mg of protein. The gangliosides in a-EAT cells were characterized as GDla and trisialogangliosides 
and, significantly, a-EAT cells did not contain monosialogangliosides. Neutral glycolipids were isolated from both 
cell lines and their patterns were compared. In contrast to the gangliosides pattern, their neutral glycolipid patterns 
were similar. Glucosylceramide and lactosylceramide were the major components in both types of cells. In addition 
to na- and a-EAT cells, a-EAT cells were passaged in mice by intraperitoneal injection, giving rise to a third 
variant (c/m EAT cells). We analysed the gangliosides in c/m EAT cells to determine whether there was a change 
in the ganglioside pattern found in ha-EAT cells. After repeated passage of c/m EAT cells in mice, the pattern of 
gangliosides shifted to that of ha-EAT cells. Alterations of ganglioside composition may be associated with the 
growth environment of the murine peritoneal cavity; alternatively, a selection process may have occurred. 
Keywords: Ehrlich ascites tumour cells, ganglioside, glycolipid 
Abbreviations: EAT cells, Ehrlich ascites tumour cells; na-EAT cells, non-adherent EAT cells; a-EAT cells, 
adherent EAT cells; c/m EAT cells, cultured a-EAT cells passaged in mice; HPTLC, high-performance thin-layer 
chromatography; PBS, 10 mM phosphate-buffered saline, pH 7.2, containing 0.15 M NaC1; EDTA, ethylene- 
diaminetetraacetic acid; TFA, trifluoroacetic acid; TG, thioglycollate; Cer, ceramide (N~fatty acyl sphingosine); 
GM3, NeuAca2-3Gal/31-4Glc-Cer; GM2, GalNAc/31-4(NeuAca2-3)Gal/31-4Glc-Cer; GMla, Gal/31-3GalNAc/31- 
4(NeuAca2-3)Gal/31-4Glc-Cer; GD3, NeuAca2-8NeuAca2-3Gal/31-4Glc-Cer; GDla, NeuAca2-3Gal/31- 
3GalNAc/31-4(NeuAca2-3)Gal/31-4Glc-Cer; GTlb, NeuAca2-3Gal~l-3GalNAc~l-4(NeuAca2-8NeuAca2-3)Gal~l- 
4Glc-Cer; LacCer, Gal/31-4Glc-Cer; Gb3, Galal-4Gal/31-4Glc-Cer; Gb4, GalNAc/31-4Galal-4Gal/31-4Glc-Cer. 
Introduction 
Ehrlich ascites tumour  cells (EAT cells) are routinely 
grown in the peri toneal  cavi ty  o f  mice.  In previous studies 
o f  EAT cells f rom our laboratory [1, 2], the structural 
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features o f  the carbohydrate  moie ty  present  in cell surface 
glycoproteins  containing terminal  non-reducing o~-linked 
galactosyl  groups were described. During the course o f  
studies on the cell surface glycoconjugates  o f  EAT cells 
and their possible  physiological  role(s), we developed an 
EAT cell variant sys tem in wh ich  EAT cells had been 
selected to grow in cell culture, and were capable  o f  
attaching to the surface o f  culture flasks. These cells were 
referred to as adherent  EAT (a-EAT) cells to distinguish 
them f rom the asci tes-grown cells, which were referred to 
as non-adherent  EAT (na-EAT) cells. Besides differences 
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in adhesion ability, these two lines of EAT cells exhibited 
a difference in tumourigenicity [3]. Differences in cell 
surface glycoproteins and in laminin and fibronectin 
synthesis between these two EAT cell lines were studied 
using three different lectins as probes [4]. We showed that 
both EAT cell lines express surface glycoproteins reactive 
with Maackia amurensis lectin (MAL) [5, 6] and Griffonia 
simplicifotia isolectin (GS I-B4) [7]. However, only a-EAT 
cells react with elderberry (Sambueus nigra) bark tectin 
(SNA) [8] suggesting that there are some differences in 
the sialylation of cell surface carbohydrate moieties 
between the two EAT cell lines. In connection with these 
studies, we also showed a-EAT cells exhibited a selective 
increase in the activity of a-2,6-N-linked sialyltransferase 
activity [9]. Recent reports indicate that there is an 
increase in the N-linked o~-2,6- but not a-2,3-sialyltrans- 
ferase in human colorectal cancer compared to poorly 
metastic tissues [10]. These results suggested the EAT cell 
system may serve as a good experimental model for the 
investigation of sialyltransferases and their cell surface 
sialylated products in relation to cancer, metastasis, and 
cell-cell interactions. 
As an extension of these studies on glycosylation and 
cell adhesion, we are interested in the glycosylation 
patterns of glycolipids in EAT cells, since alterations in 
glycolipid composition have been observed in a variety of 
experimental tumours as well as human cancer [11, 12]. 
In particular, gangliosides are important constituents of 
cellular membrane and are considered to play a role in 
cellular interactions, growth control or adhesiveness of 
cells [13, 14]. In this report, we described differences that 
exist in the ganglioside patterns between two EAT cell 
lines. In addition to the analysis of  the gangliosides in 
na- and a-EAT cells, we studied the gangliosides present 
in a-EAT cells that had been reintroduced into and 
passaged in the peritoneal cavity of  the mice in order to 
determine whether there is a change in the pattern found 
in na-EAT cells. 
Materials and methods 
Materials 
CD-1 female mice, 25-30 g, were obtained from Charles 
River, Portage, MI. DEAE Sephadex A-25 and neurami- 
nidase (Vibrio chlorae) were purchased from Sigma. 
Ceramide-glycanase (Leech, Marobdella decora) was 
from V-LABS, Inc, LA. Gangliosides and neutral glyco- 
sphingolipids used as standards were from Matreya Inc. 
High-performance thin-layer chromatography (HPTLC) 
plates were from E. Merck, Darmstadt, FGR. 
Maintenance and preparation of na-EAT cells 
EAT cells were maintained by weekly intraperitoneal 
injection of 0.4 ml of ascites fluid (approximately 4 × 10 7 
cells) into CD-1 female mice. The ascites cells and fluid 
were centrifuged at 1000rpm (International portable 
refrigerated centrifuge, Model PR-2) and separated into 
supernatant and cell fractions, in order to remove 
contaminating intact and broken cells, the supernatant 
solution was centrifuged at 5000rpm for 10rain. The 
cell-free supernatant was lyophilized and used as an 
ascites fluid fraction. The cells were washed repeatedly 
with PBS. 
a-EAT cell culture 
a-EAT cells, selected from the ascite EAT cells [3] were 
cultured in 75 cm 2 culture flasks containing Dulbecco's 
modified Eagle's medium (DMEM) (GIBCO) and 10% 
fetal bovine serum (GIBCO). Cells were subcultured 
weekly, a-EAT cells were harvested using a buffer 
containing 5 mM EDTA, were washed three times with 
PBS, and were stored at - 2 0  °C until use. 
Preparation of c/m-EAT cells 
A third variant of EAT cells was derived by intraperitoneal 
injection of the a-EAT cells (approximately 4 × 10 7 cells) 
into CD-1 mice and continued passage of the resulting 
ascitic tumour cells. This variant was designated as 
cultured cells grown in mice (c/m-EAT cells). The first 
passaged cells were designated c/m 1. c/m 2 EAT cells 
were a-EAT cells that were reintroduced into mice and 
passaged two times, etc. The cell fractions were prepared 
in the same manner as na-EAT cells. 
Preparation of thioglycollate (TG)-stimulated ascites 
fluid 
TG-stimulated ascites fluid was obtained from mice that 
had been injected intraperitoneally with 2ml  of 3% 
solution of Brewer's modified TG medium (Becton 
Dickinson Microbiology systems, MD) prepared according 
to the manufacturer's instructions. Three to 4 days after 
the TG stimulation, the mice were killed, after which 3 ml 
of PBS was injected into the peritoneal cavity. The ascites 
fluid (approximately 3-4 ml per mouse) was withdrawn 
and centrifuged to remove the peritoneal cells. The 
supernatant was lyophitized and subjected to glycotipid 
extraction. 
Extraction and subsequent fi'actionation of glycolipids 
Packed cells (10ml) were extracted with 35ml of 
isopropanol:hexane:water (55:25:20, v/v) by sonication 
for 5 rain and centrifuged. The pellet was extracted again 
with 35 ml of the same solvent. Subsequently the residue 
was extracted by sonication for 5rain in 35ml of 
chloroform:methanol (2:1). Finally, the residue was 
extracted with 35 ml of chloroform:methanol (1:2) con- 
taining 5% water by sonication for 5 rain. The extracts 
were combined, evaporated to dryness, dissolved in 60 ml 
of chloroform:methanol (2:1), and partitioned according to 
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the method of Folch [15]. The glycolipids in the upper 
phase of the Folch partition were subjected to DEAE- 
Sephadex A-25 column chromatography. The neutral 
glycolipids were eluted with chloroform:methanol:water 
(30:60:8). Gangliosides were separated into mono-, di-, 
and trisialogangliosides fractions by stepwise elution with 
0.015, 0.15, and 0.45 M ammonium acetate in methanol, 
respectively. The final isolation of individual gangliosides 
was performed by preparative TLC with precoated Silica 
Gel 60 plates (E. Merck) by solvent system A (see below). 
Lipid extracts in the lower phase were subjected to 
saponification, acetylation, and fraction by Silica gel 
column chromatography [16]. The glycolipid fractions 
were combined and evaporated. In order to remove 
contaminents from the glycolipid fractions, the glycolipids 
were subjected to Silica gel column chromatography a 
second time, and fractionated by stepwise elution with 
chloroform:methanol (4:1, 1:1 and 1:3, v/v) and methanol 
[17]. Glucosyl ceramides and other glycolipids were 
recovered in the chloroform:methanol (4:1 and 1:1) 
fractions, respectively. 
Gangliosides and neutral glycolipids were analysed 
by HPTLC. The follovdng solvent systems were used: 
A, chloroform:methanol:0.25% KC1 (50:40:10); B, 
chloroform:methanol:water (65:25:4); C, chloroform: 
methanol:water (65:35:8). Gangliosides and neutral glyco- 
sphingolipids were visualized by spraying with the 
resorcinol-hydrochloric acid reagent [18] and the orcinot 
reagent [19], respectively. 
Quantitative determination of gangliosides 
Gangliosides were determined by the resorcinol assay [18]. 
The proportion of individual gangliosides in a TLC plate 
was quantified by densitometry using an Apple Macintosh 
Centris 650 computer and NIH Image program (NIH 
Image 1.49). 
Characterization of isolated gangliosides 
The carbohydrate compositions were analysed by Dionex 
HPLC. A ganglioside, approximately 1 nmol, was hydro- 
lysed with 2 M trifluoroacetic acid for 4 h at 100 °C. The 
hydrolysate was subjected to HPLC and eluted with 8 mM 
NaOH. Gangliosides were assayed by neuraminidase 
hydrolysis in 100 gl of 20 mM tris-maleate buffer (pH 
6.5) containing 4raM CaC12 and 0.5% Triton X-100 at 
37 °C overnight. Chemical desialylation of gangliosides 
was performed by incubation in 2% acetic acid at 100 °C 
for 1 h [20] or 1 M formic acid at 100°C for 2h  [21]. 
Ceramide-glycanase hydrolysis was conducted according 
to Li et al. [22]. The incubation mixture contained 
ganglioside, 10 nmol; sodium cholate 150 gg; and 0.2 U 
of enzyme in 200 gl of 50 mM acetate buffer, pH 5.0 for 
18 h. For molecular weight determination, laser desorption 
mass spectrometry (LD-MS) of an isolated ganglioside 
was performed in the linear mode. 
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Results 
Gangliosides of na- and a-EAT cells 
The content and composition of gangliosides in na- and a- 
EAT ceils are shown in Tables 1 and 2, and Figure 1A. As 
clearly shown, na-EAT cells contained a significant 
amount of gangliosides. On the other hand, the content 
of lipid-bound sialic acid in a-EAT cells was only 15.3% 
of that in na-EAT cells based on protein content, and 
accounted for 14.4% of that in ha-EAT cells based on total 
phosphate content. Qualitative and quantitative analyses of 
gangliosides were carried out by HPTLC. As shown in 
Fig. 1, na-EAT cells contain at least 12 different kinds of 
mono-, di-, and trisialogangliosides, as eluted stepwise by 
increasing concentration of ammonium acetate in DEAE- 
Sephadex column chromatography. However, the gangtio- 
sides present in a-EAT cells were obtained only from the 
0.15 M ammonium acetate fraction, a-EAT cells contained 
di- and trisialogangliosides, similar to those in na-EAT 
ceils, but a-EAT cells did not contain any monosialogan- 
gliosides. 
Qualitative analyses of neutral glycolipids in ha- and a- 
EAT cells were carried out by HPTLC (Fig. 2). Major 
glycolipids were recovered in the chloroform:methanol 
(1:1) fraction by Silica gel column chromatography. In 
addition, a fraction containing glucosylceramide (Glc-cer) 
was obtained from the chloroform:methanol (4:1) fraction 
under our experimental conditions. In contrast to the 
gangliosides pattern of the two cell lines, the pattern of 
their neutral glycolipids was similar. Both cells contained 
the globo series of neutral glycolipids, e.g. Glc-cer, 
lactosylceramide (Lac-cer), globotriaosylceramide (Gb3) 
and globoside (Gb4), based on comparison of their 
migratory rates with those of authentic neutral glycoli- 
pids. The intensely stained components migrating faster 
than Glc-cer which could be non-polar tipids were 
incompletely separated. They gave a brownish colour 
rather than the purple colour given by carbohydrate- 
containing components stained by Orcinol. 
Table 1. Content of  lipid-bound sialic acid in EAT cells and the 
extracellular fluid. 
Lipid-bound sialic acid (nmol) 
per mg pet" 10 s 
protein cells 
per pmol of  
phosphate a 
na-EAT 1.57 29.33 5.55 
a-EAT 0.24 4.11 0.80 
c/m 1 1.53 28.21 5.25 
c/m 2 1.48 26.85 5.08 
c/m 10 1.28 23.09 4.44 
Ascites fluid 0.80 25.57 ND 
aTotal phosphate was quantified by the Ames method [28]. 
ND, not determined. 
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Table 2.Relative content of ganglioside components. 
Kishida and Goldstein 
ha-EAT a-EAT 
(%) (%) 
Monosialogangliosides 67.8 - 
Disialogangliosides 30.0 54.8 
Trisialogangliosides 2.2 45.2 
AF ~ c/m 1 c/m 2 c/m 10 
(%) (%) (%) (%) 
73.0 51.2 55.4 57.6 
27.0 44.5 39.8 39.8 
- 4.3 4.8 2.6 
Mono GM 3 10.2 - 
A1 - - 
GM 2 22.3 - 
GM 1 28.4 - 
A2 4.7 - 
A3 2.2 - 
Di B1 - - 
B2 - - 
GD 3 3.1 - 
B3 tr. - 
GDla 24.9 54.8 
B4 2.0 
Tri C1 tr. - 
C2 0.3 - 
C3 1.3 45.2 
3.5 2.3 4.5 6.2 
- 0.7 ~. - 
6 3 . 1  8.6 15.9 20.1 
6.4 37.2 28.0 31.3 
- 1.6 4.1 m 
- 0 . 8  2 . 9  - 
- - 1 . 0  - 
- - 0 . 5  - 
- 8 . 7  5 . 7  7 . 2  
- 1 . 4  - - 
2 6 . 6  32.5 32.0 31.1 
- 1.9 0.6 1.5 
- 1 . 5  0 . 8  0 . 6  
- 1 . 4  1 . 3  0 . 8  
- 1 . 4  2 . 7  1 . 2  
aascites fluid 
tr., trace. 
Gangliosides of  na-EAT cells were further fractionated 
by preparative TLC and their carbohydrate composition 
was analysed by Dionex HPLC. The major gangliosides 
present in na-EAT cells were characterized as GM3, 
GM2, GMla ,  GD3 and GDla,  based on the following 
results. (a) The doublet components having similar 
HPTLC mobility to GM3 were characterized as GM3, 
inasmuch as sialidase (Vibrio cholerae) treatment and 
mild acid hydrolysis converted them to lactosylceramide; 
(b) the second doublet components were GM2, since they 
were not hydrolysed by the sialidase and gave neutral 
glycolipids with the same HPTLC mobility as asialo- 
GM2 following mild acid hydrolysis; (c) the third 
components were identified as G M l a  on the basis of  
insusceptibility to sialidase - they gave asialo-GM1 
following mild acid hydrolysis; (d) the doublet disialo- 
gangliosides having HPTLC mobility identical to that of  
GD3 were characterized as GD3, since sialidase treatment 
and mild acid hydrolysis converted them to lactosylcer- 
amide: (e) four components having HPTLC mobilities 
similar to that of  G D l a  were characterized as G D l a  
species, inasmuch as they were converted to GM1 and 
asialo-GMl, following sialidase treatment and mild acid 
hydrolysis, respectively. 
Concerning the structures of  C1, C2 and C3 which 
were eluted with 0.45 M ammonium acetate in DEAE 
column chromatography, the results of  the sialidase 
treatment and mild acid hydrolysis showed that they 
contain the asialo-GM1 backbones, suggesting they are 
probably GTlb.  
A minor monosialoganglioside (A2) migrating slightly 
slower than GM1 (RGM1 0.96 in chloroform:metha- 
nol:0.25% KC1, 50:40:10)was  isolated. This A2 gang- 
lioside was resistant to sialidase treatment. A2 was 
converted to a neutral glycolipid with the same TLC 
mobility as asialo GM1 following mild acid hydrolysis. 
LD-MS of  A2 showed several fragments from the 
carbohydrate chain. The ions at 1264, 1555, and 1741 
corresponded to molecular weights of  asialo GM1, GM1 
and A2, respectively. After ceramide-glycanase treatment, 
the migration of  released oligosaccharide from A2 on 
HPTLC (in n-butanol:acetic acid:water, 2:1:1) was slower 
than that o f  authentic GM1. These results suggest that A2 
contains an additional carbohydrate residue attached to 
GM1. However A2 was resistant to the enzymatic action 
of  a-L-fucosidase from bovine kidney. Since the amounts 
of  available materials were low, further structural analyses 
of  A1-3 and B1-4 could not be carried out. 
Since a-EAT cells contain a-2,6-1inked sialic acid on 
their cell surface glycoconjugates as revealed by their 
agglutination with the Sambucus nigra (SNA) lectin, we 
employed an HPTLC overlay procedure to determine if 
this linkage is present on glycolipids. Initially, we used 
horse radish peroxidase (HRP) labelled slug lectin Limax 
flavas agglutinin (LFA), which reacts with sialic acid in 
any linkage [23], following TLC separation. Gangliosides 
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Figure2. Thin-layer chromatogram of neutral glycolipids in 
Folch's lower phase from ha- and a-EAT cells. Neutral glycolipids 
were fractionated by stepwise elution with chloroform:methanol in 
Silica gel column chromatography as described under 'Materials 
and methods'. Lane 1, authentic neutral glycolipids of GlcCer, 
LacCer, Gb3 and Glob (from top to bottom); Lane 2, neutral 
glycolipids recovered from chloroform:methanol (4:1 and 1:1) of 
na-EAT cells; Lanes 3 and 4, neutral glycolipids from a-EAT cells; 
Lane 3, chloroform:methanol (1:1); Lane 4, chloroform:methanol 
(4:1). The solvent system for TLC was chloroform:methanol:water 
(65:25:4). The bands were visualized with the copper-phosphoric 
acid reagent. Arrows indicate the orcinol positive bands. 
Figure 1. Thin-layer chromatograms of gangliosides from EAT 
cells and ascites fluid. (A) Lane 1, authentic monosialogangliosides 
(from top to bottom: GM3, GM2, GM1); Lane 2, authentic 
disialogangliosides (from top to bottom: GD3, GDla, GDtb); 
Lanes 3-5, gangliosides eluted by increasing concentration of 
ammonium acetate in DEAE-Sephadex column chromatography of 
glycolipids from Folch's upper phase of na-EAT cells; Lane 3, 
0.015 M; Lane 4, 0.15 M; Lane 5, 0.45 M; Lane 6, gangliosides 
from a-EAT cells. (B) Lane 1, authentic gangliosides of GM3, 
GM2, GM1, GD3, GDla and GDlb (from top to bottom); Lane 2, 
monosialogangliosides fraction from the ascites fluid; Lane 3, 
disialogangliosides fraction from the ascites fluid. The solvent 
system for TLC was chloroform:methanol:0.25% KC1 in water 
(50:40:10, v/v/v). Gangliosides were visualized with the resorcinol- 
HC1. Arrows indicate the resorcinol positive bands. A2, A3, 
B3, B4, C1, C2 and C3 are minor gangliosides of unknown 
structure. 
in both cell lines were detected by this HPTLC lectin 
overlay method using HRP-LFA. However, no positive 
reaction o f  gangliosides with HRP-SNA was detected in 
either na- or a-EAT cells, suggesting the absence of  a -  
2,6-1linked sialic acid in gangliosides in both cell lines; 
the HRP-SNA lectin was shown to react with fetuin 
which contains a-2,6-1inked sialic acid. 
Characterization of  gangliosides in ascites fluid 
As shown in Table 1, the content o f  lipid-bound sialic acid 
in the extracellular fluid from ha-EAT cells was 0.80 nmol 
per mg protein. The ganglioside pattern of  ascites fluid, as 
shown in Fig. 1B, was extremely simple as compared to 
that o f  the cell fraction. The two major gangliosides 
comigrated with standard GM2 and GDla .  Further 
characterization by sialidase treatment and mild acid 
hydrolysis confirmed this assignment. 
As a control for the gangliosides present in ascites 
fluid from EAT cells-bearing mice, gangliosides in the 
ascites fluid present in mice containing no tumour were 
prepared. The ascites fluid was obtained from mice which 
were injected intraperitoneally with thioglycollate (TG). 
Several kinds of  monosialogangliosides such as GM3, 
GM2 and GM1 were detected. Among them GM1 was 
the major ganglioside constituent o f  the ascites fluid from 
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non tumour-bearing mice. GMt present in the ascites 
fluid might be related to the GM1 present in macro- 
phages that is the predominant ganglioside of  TG- 
stimulated mouse macrophage [24]. The ascites fluid 
did not contain any disialogangliosides. Besides mono- 
sialogangtiosides, a few resorcinol-positive bands were 
also detected in the region of  trisialogangliosides. Further 
fractionation of  the gangliosides was not attempted due to 
the low amount of available material. 
Gangliosides in c/m EAT cells 
The ganglioside profiles of c/m 1 and c/m 2 cells are 
shown in Fig. 3. Although the ganglioside content of a- 
EAT cells was extremely low, the levels of  lipid-bound 
sialic acid in c/m 1 cells returned to that of na-EAT cells 
(Table 1). One of  the significant differences in the 
ganglioside patterns was that GM1 accumulated in c/m 
1 cells. It is possible that the /3-galactosidase present in 
ascites fluid might affect the production of  GM1 from 
GM2 [25]. At this point, it is difficult to decide whether 
GM2 in ascites fluid is a precursor for GM1. Ten 
consecutive passages in mice were carried out and the 
gangliosides extracted from the c/m 10 cells, as shown in 
Fig. 4. The general trend observed with successive 
passages was a reduction in the proportion of disialogan- 
gliosides with a concomitant increase in the percentage of  
monosialogangliosides. In addition, the relative content of 
GD3 in c/m 1 cells was highest among the cell lines in 
this study. The GD3 content decreased with successive 
passages, with an increase in GM3. The pattern of c/m 1 
cells was intermediate between ha- and a-EAT cells. The 
characterization of gangliosides in c/m 2 cells shifted to 
that present in na-EAT cells. 
A preliminary experiment regarding the ability of c/m 
EAT cells to adhere to tissue culture plastic was 
conducted. Under the experimental conditions described, 
na-EAT cells did not attach to tissue culture plastic. In 
contrast, -70% of c/m 1 and c/m 2 EAT cells attached to 
tissue culture plastic 18 h after plating. It required 2 and 
3 days, respectively, for c/m 1 and c/m 2 EAT cells to 
spread on plastic, while it required 2-3 h for a-EAT cells 
to spread. Even after 10 passages in mice, cells had not 
completely lost their ability to adhere, since approxi- 
mately 50% of c/m 10 EAT cells adhered 5 days after 
plating. Although c/m 10 EAT cells attached and were 
cultured for 2 weeks, they did not spread on plastic. Thus 
c/m EAT cells showed different attachment and spreading 
properties from those of a-EAT cells. 
Figure 3, Thin-layer chromatograms of gangliosides from c/m 1 
(A) and c/m 2 (B) EAT cells. Lane 1, authentic gangliosides of 
GM3, GM2, GM1, GD3, GDla and GDlb (from top to bottom); 
Lane 2, monosialoganglioside fraction; Lane 3, disialoganglioside 
fraction; Lane 4, trisialoganglioside fi'action. The solvent system 
for TLC was chloroform:methanol:0.25% KC1 in water (50:40:10, 
v/v/v). Gangliosides were visualized with resorcinol-HC1. A1, B1 
and B2 are minor gangliosides of unknown structure. 
Figure 4. Thin-layer chromatogram of gangliosides from c/m t0- 
EAT cells. Lane 1, authentic gangliosides of GM3, GM2, GMt, 
GD3, GDla and GDlb (from top to bottom); Lane 2, mono- and 
disialogangliosides fraction; Lane 3, trisialoganglioside fraction. 
The solvent system for TLC was chloroform:methanol:0.25% KC1 
in water (50:40:10, v/v/v). Gangliosides were visualized with 
resorcinol-HC1. Arrows show the resorcinol positive bands. 
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Discussion 
Our data show that the pattern of gangliosides present in 
a-EAT cells differed significantly from that in na-EAY 
cells, both qualitatively and quantitatively, a-EAT cells did 
not contain monosialogangliosides and the gangtiosides 
present were characterized as GDla and GTlb. Several 
studies suggested that di- or trisialogangliosides such as 
GDla and GTlb of tumour-cell origin may assist the 
tumour in the development of metastatic capacity [26]. 
The role of gangliosides present in a-EAT cells remains 
unclear. 
Isolation of gangliosides present in ascites fluid from 
tumour-bearing mice was performed to determine if the 
ganglioside pattern difference in the two cell lines is due 
to differences in their growth environment. GM2 and 
GDla were found to accumulate in the ascites fluid 
fraction, This observation differed from the ganglioside 
composition of thioglycollate-stimulated ascites fluid, 
which contains at least six kinds of monosialigangliosides 
and no disialoganglioside. In a previous study on the role 
of GM2, it was suggested that the growth rate and size of 
human melanoma are proportional to the content of GM2 
in the log phase of  the tumour growth [27]. However, the 
role of gangliosides in tumour-bearing mouse ascitic fluid 
is at present unknown. The tumour bearers' serum 
ganglioside profile closely resembled that of tumour 
tissue and differed from that of normal serum [27]. The 
significant amount of GM2 in tumour bearing mice 
ascites fluid might be of host origin, produced as a result 
of  host-tumour interaction. Additionally, GM2 and GDla, 
which are characteristic gangliosides in ascites fluid in 
tumour-bearing mice, might be related to the formation 
of EAT cell gangliosides. 
We analysed gangliosides in a-EAT cells that were 
reinjected into the murine peritoneal cavity to determine 
whether there was a change in the ganglioside pattern 
found in na-EAT cells as influenced by a change in the 
physiological milieu of the murine peritoneal cavity. Our 
findings with respect to the contents and patterns of 
gangliosides in EAT cells are as follows: (i) the content 
of lipid-bound sialic acid in the a-EAT cell line is ca. 
15% of that in either na-EAT or c/m cell lines; (ii) the 
level of lipid-bound sialic acid was significantly elevated 
for c/m 1 cells compared to a-EAT cells; (iii) it was 
necessary to passage a-EAT cells through only two 
successive animals before they reverted to the ganglioside 
patterns characteristic of  na-EAT cells. An alternate 
interpretation is that a selection process may have 
occurred. In contrast to the glycosylation of gangliosides 
in EAT-cell lines, our previous studies showed that a 
change in c/m cells glycosylation pattern appeared after 
25 passages in that their reactivity with lectins and the 
extent of glycosylation of their glycoproteins resembled 
na-EAT cells [3]. These results suggest that a stimulation 
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factor for tumour cell-associated ganglioside synthesis 
may exist in the murine peritoneal cavity, and that the 
sialylation of glycolipids might be controlled by an 
independent sialyltransferase, distinct fiom that of 
glycoprotein sialylation. Other investigators showed that 
the extracellular environment can affect ganglioside 
metabolism [29, 30]. The study on the interaction of the 
gangliosides present in the peritoneal cavity with those in 
the tumour cells is a subject for further investigation. 
Another purpose of this study was to determine 
whether ~-2,6-1inked sialic acid is present on glycolipids 
and/or glycoproteins, inasmuch as a-EAT cells contain 
this linkage as revealed by their agglutination assay with 
the SNA lectin. Both ECL Western blotting products 
(Amersham Life Science) and a combination of perox- 
idase with 4-chloronaphthol were used for the detection 
of siallc acid following the separation of gangliosides on 
TLC and the reaction with the lectin. However, no 
positive reaction of the ganglioside with HRP-SNA was 
detected in either na- or a-EAT cells. Although our 
previous work showed a-EAT cells exhibited a selective 
increase of two- to five-fold over na-EAT cells in the 
activity of oz-2,6-N-linked sialyltransferase activity, there 
is no correlation between the expression of o~-2,6- 
sialyltransferase activity and the presence of o~-2,6- 
sialylated glycolipids in this study, as previously reported 
in the literature [10]. 
A search of the literature indicates that there does not 
appear to be a good correlation between cell adhesion 
and content and nature of gangliosides [14]. No direct 
relationship has been demonstrated in this study. As 
noted in the result section, our preliminary experiments 
indicate that c/m cells exhibit attachment properties 
different from those of a:EAT cells. We plan to examine 
in more detail the ability of c/m cells to adhere to and 
spread on various components of the extracellular matrix. 
This could be a good system to gain insight into the 
metastatic properties of tumour cells. 
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